Medical specialists from France tagged as investigators in clinical trials studying Neoplasms, Plasma Cell
Total 102 results
-
Amine BELHABRISeen in:
- Lyon, Centre Léon Berard
Trials:- NCT04052126 (Sub-Investigator)
- NCT04671693 (Sub-Investigator)
- NCT05947136 (Sub-Investigator)
Conditions:- Quality of Life;
- Lymphoma, Non-Hodgkin;
- Leukemia, Myeloid, Acute;
- Fatigue;
- Exercise;
- Aged;
- Aged, 80 and Over;
- Acute Myeloid Leukemia;
- Hodgkin Disease;
- Osteosarcoma;
- Non Hodgkin Lymphoma;
- Late Effects;
- Ewing's Sarcoma;
- Testicular Germ Cell Tumor Mixed;
- Non-Metastatic Breast Carcinoma;
- Soft Tissue Sarcoma, Adult, Stage IIC;
- Multiple Myeloma;
- Complication
-
Anne Banos, MDSeen in:
- Bayonne, CH de la Côte Basque
- Bayonne, Centre Hospitalier de la Côte Basque
- Bayonne, Ch La Cote Basque
- Bayonne, Hematology Service - CH de la cote basque
Trials:- NCT03503409 (Principal Investigator)
- NCT01976182 (Principal Investigator)
- NCT02066454 (Principal Investigator)
- NCT03744390 (Principal Investigator)
- NCT03223961 (Principal Investigator)
-
Anne DEVILLERS, MDSeen in:
- Rennes, Centre Eugene Marquis
Trials:- NCT03832127 (Principal Investigator)
- NCT03951337 (Principal Investigator)
Conditions: -
Anne Parry, MDSeen in:
- Annecy, CHRA
- Annecy, Ch Annecy Genevois
Trials:- NCT02066454 (Sub-Investigator)
- NCT05963061 (Sub-Investigator)
Conditions: -
Anne THIEBAUT, MDSeen in:
- Grenoble, CHU Grenoble
Trials:- NCT02066454 (Sub-Investigator)
Conditions: -
Anne-Marie StoppaSeen in:
- Marseille Cedex 9, GSK Investigational Site
Trials:- NCT04484623 (Principal Investigator)
Conditions: -
Anne-Sophie MICHALLETSeen in:
- Lyon, Centre Léon Berard
Trials:- NCT04052126 (Sub-Investigator)
- NCT04671693 (Sub-Investigator)
- NCT02029001 (Sub-Investigator)
- NCT05947136 (Sub-Investigator)
Conditions:- Quality of Life;
- Lymphoma, Non-Hodgkin;
- Leukemia, Myeloid, Acute;
- Fatigue;
- Exercise;
- Aged;
- Aged, 80 and Over;
- Acute Myeloid Leukemia;
- Hodgkin Disease;
- Osteosarcoma;
- Non Hodgkin Lymphoma;
- Late Effects;
- Ewing's Sarcoma;
- Testicular Germ Cell Tumor Mixed;
- Non-Metastatic Breast Carcinoma;
- Soft Tissue Sarcoma, Adult, Stage IIC;
- Malignant Solid Neoplasms;
- Multiple Myeloma;
- Complication
-
Audrey SIMON, MDSeen in:
- Grenoble, CHU Grenoble
Trials:- NCT02066454 (Sub-Investigator)
Conditions: -
Aurore PerrotSeen in:
- Midi-pyrenees, Toulouse, Centre Hospitalier Universitaire de Toulouse Hopital Purpan
- Toulouse cedex 9, GSK Investigational Site
- Toulouse, CHU Toulouse
- Toulouse, University Hospital Toulouse
- West-Occitanie, Toulouse, IUCT-Oncopole - Toulouse University Hospital
Trials:- NCT03215030 (Principal Investigator)
- NCT04484623 (Principal Investigator)
- NCT05101759 (Sub-Investigator)
- NCT04888039 (Principal Investigator)
- NCT06062537 (Principal Investigator)
Conditions: -
Axelle LASCAUX, MDSeen in:
- Pessac, CHU Bordeaux
Trials:- NCT02066454 (Sub-Investigator)
Conditions: -
Bernadette CORRONT, MDSeen in:
- Annecy, CHRA
Trials:- NCT02066454 (Sub-Investigator)
Conditions: -
Brigitte PEGOURIE, MDSeen in:
- Grenoble, CHU Grenoble
Trials:- NCT02066454 (Principal Investigator)
Conditions: -
Carine CHALETEIXSeen in:
- Clermont-Ferrand, Chu Clermont-Ferrand
Trials:- NCT02976272 (Principal Investigator)
Conditions: -
Carla ARAUJO, MDSeen in:
- Bayonne, Ch La Cote Basque
Trials:- NCT02066454 (Sub-Investigator)
Conditions: -
Caroline Bodet Milin, MD, PhDSeen in:
- Nantes, Nantes UH
Trials:- NCT04561492 (Principal Investigator)
Conditions: -
Caroline bodet Mion, MDSeen in:
- Nantes, CHU de Nantes
Trials:- NCT03832127 (Principal Investigator)
Conditions: -
Caroline Lejeune, MDSeen in:
- Saint-Etienne, Chu de Saint-Etienne
- Saint-Étienne, Chu de Saint-Etienne
Trials:- NCT03439371 (Sub-Investigator)
- NCT04517656 (Sub-Investigator)
- NCT05259553 (Sub-Investigator)
-
Catherine SEBAN, MDSeen in:
- Lyon, Centre Léon Berard
Trials:- NCT02066454 (Sub-Investigator)
Conditions: -
Cecile BallySeen in:
- Paris, Hopital Necker
Trials:- NCT02649790 (Principal Investigator)
-
Cecile SonntagSeen in:
- Alsace, Strasbourg, Institut de cancerologie Strasbourg Europe
Trials:- NCT03215030 (Principal Investigator)
Conditions: -
Célestine SIMAND, MDSeen in:
- Strasbourg, Institut de cancerologie Strasbourg Europe
Trials:- NCT05786105 (Principal Investigator)
Conditions: -
Charles ZARNITSKY, MDSeen in:
- Montivilliers, Groupe Hospitalier Du Havre
Trials:- NCT02066454 (Principal Investigator)
Conditions: -
Claude-Eric BULABOIS, MDSeen in:
- Grenoble, CHU Grenoble
Trials:- NCT02066454 (Sub-Investigator)
Conditions: -
Clement GourguechonSeen in:
- Amiens Cedex 1, UH Amiens CEDEX 1
Trials:- NCT05879757 (Principal Investigator)
Conditions: -
Cyrille TouzeauSeen in:
- Nantes, Centre Hospitalier Universitaire de Nantes
- Nantes, Centre Hospitalier Universitaire de Nantes (Chu de Nantes) - Hotel-Dieu
- PAYS DE LA Loire, Nantes Cedex 1, Centre Hospitalier Universitaire Nantes - Hotel Dieu
Trials:- NCT03215030 (Principal Investigator)
- NCT04184050 (Principal Investigator)
- NCT05651932 (Principal Investigator)
-
DAGUINDAU Nicolas, MDSeen in:
- Annecy, CHRA
Trials:- NCT02066454 (Sub-Investigator)
Conditions:
Clinical Trials on Neoplasms, Plasma Cell
-
IRCCS Centro di Riferimento Oncologico della BasilicataCelgene CorporationCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Plasma Cell LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRefractory Plasma Cell Myeloma | Plasmacytoma | Recurrent Plasma Cell Myeloma | Plasma Cell LeukemiaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnPlasma Cell Myeloma | Plasma Cell Leukemia in RemissionUnited States
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)TerminatedRefractory Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell Myeloma | DS (Durie/Salmon) Stage I Plasma Cell MyelomaUnited States
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
Emory UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; National Institutes...CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | ISS Stage III Plasma Cell Myeloma | ISS Stage II Plasma Cell Myeloma | ISS Stage I Plasma Cell MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
National Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States